Search
Search
Close this search box.

CBD’s High St March Takes All Before It

HIGH END British department store Selfridges has listed the CBD range of a new UK start-up which has also been boosted by a 847,000 Euro investment.

London-based Grass & Co was launched last year by experienced entrepreneur Ben Grass, and has quickly made rapid market strides.

Its tie-up with Selfridges will see the leading department store stock a range of its CBD products in its London and Manchester outlets and on its website selfridges.com.

The company has also closed an €847,000 seed financing round backed by a number of experienced angel investors.

Toby Gordon-Smith, CEO, Grass & Co said its is ‘committed to producing a quality, ethically sourced CBD product free from pesticides and herbicides that consumers can trust’.

Selfridges currently stock Kiki Health CBD products and its latest CBD deal will see it carry Grass & Co’s Ease and Calm ranges, which include body oils and muscle balms.

Selfridges is the latest major high street brand to succumb to the CBD juggernaut – with over one million daily users in the U.K. the market is set to be worth over £1bn within a few years.

World-renowned London brand Harrods now stock a range supplied by Dragonfly Biosciences, whilst Tesco recently launched a range supplied by Vitality CBD.

Both UK health food shop Holland & Barrett and health and wellness,  and pharmacy chain Boots also stock and sell CBD products.

🔒 Risk Management Report • Produced in partnership with RELM
Prohibition Partners RELM
📊 New Report Available Now

Relm Risk Briefing: Cannabis 2026

The global cannabis sector has moved from experiment to enterprise. This comprehensive risk briefing examines how regulation, insurance, and operational practices intersect across the international supply chain, drawing on insights from RELM—the only insurer entirely dedicated to the cannabis industry.

What's covered

  • 🌱 Cultivation risk management — biological contamination, environmental instability, and security protocols
  • ⚗️ Manufacturing & extraction — GMP standards, in-house testing, and quality control measures
  • 🔬 Testing & compliance — rigorous protocols ensuring product safety and regulatory adherence
  • 📦 Distribution & logistics — GDP-aligned transport, route monitoring, and cargo insurance
Key focus areas
Cultivation Manufacturing Testing & QC Packaging Distribution Retail & Pharmacy
100% free • Comprehensive risk analysis

Key insights

Industry Maturity Cannabis has evolved from patchwork markets to international enterprise, with risk management now the measure of long-term stability.
Cultivation Challenges Operators addressing biological contamination through controlled-environment agriculture, tissue culture, and IPM protocols.
Quality Control GMP adherence, in-house testing, and selective supplier relationships emerging as critical control points.
Supply Chain Security GDP-aligned transport, route monitoring, and comprehensive insurance remain essential safeguards.
Market Access Initiatives stabilizing domestic supply and expanding pharmacy training improving patient and consumer access.
Produced by Prohibition Partners in collaboration with RELM—the only insurer dedicated to emerging industries like cannabis.
Partnership
Produced by Prohibition Partners in collaboration with RELM

Related Posts

Related Posts

CONNECT

Related Posts

Related Posts

Recent Posts

Related Posts

Subscribe to our mailing list to receives daily updates!

We won’t spam you

Categories

Browse by Tags

CATEGORIES

EDITION

BUSINESS OF CANNABIS

© 2023 Prohibition Holdings Ltd. All Rights Reserved.

EDITION

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?